Translating Biomolecular Condensates in Cancer: From Discovery to Clinical Application
Join the Division of Cancer Diagnosis and Treatment (DCTD) and the Division of Cancer Biology (DCB) for this hybrid in-person and virtual workshop to explore how advances in biomolecular condensate biology can be translated into cancer biomarkers, therapeutic targets, and intervention strategies. Registration is open now for all interested attendees!
Biomolecular condensates are increasingly recognized as key regulators of cancer biology, influencing processes such as transcription, chromatin organization, DNA-damage responses, RNA splicing, oncogenic signaling, and therapeutic resistance. This workshop will bring together leaders from academia, industry, and NIH to explore how advances in condensate biology can be translated into clinically meaningful biomarkers, diagnostics, and therapies. Over two days, the workshop will address the foundations of condensate biology in cancer, emerging platforms to measure condensate states and function, approaches for linking condensate measurements to cancer-relevant phenotypes, and therapeutic strategies targeting condensate-driven mechanisms. Industry case studies and NIH partnership and funding pathways will further highlight opportunities to accelerate translation from discovery to clinical application.
Visit the event website here for more details and updates.